255 results on '"Wo, J.Y."'
Search Results
2. Molecular Mechanisms of Intratumoral Nerve Recruitment and Perineural Invasion Elucidated with Spatial Transcriptomics and CRISPR Activation
3. Intercellular Mechanisms of Therapeutic Resistance at the Tumor-Stromal Interface Using Ultra High-Plex Single-Cell Spatial Transcriptomics and Genetically-Engineered Tumoroids
4. Association between Liver Metastases and Treatment Response in Patients with Metastatic, Microsatellite Stable Colorectal Cancer Treated with Radiation Therapy and Dual Immune Checkpoint Blockade
5. Knowledge and Understanding of Treatment Options among Patients with Gastrointestinal (GI) Cancer in an Academic Cancer Center
6. Prediction of Hepatic Toxicity after Radiotherapy Using a Neural Network Including Blood Biomarkers and Liver Dose Distributions
7. Long-Term Results of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Irradiation of Unresectable Primary Liver Tumors
8. High Baseline TNF-α Levels may Associate with Poor Outcomes after Total Neoadjuvant Therapy for Gastroesophageal Cancer: Initial Biomarker Analysis from a Prospective Study
9. The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer—a Large Single-Center Experience
10. Clinical Correlates of Portal Venous or Superior Mesenteric Vein Thrombosis Following Neoadjuvant Therapy with Dose Escalated Radiation for Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
11. The Evolving Landscape of Treatment Paradigms for Locally Advanced Rectal Cancer: A Survey Study of Gastrointestinal Radiation Oncology Experts
12. Long Term Risk of Pelvic Insufficiency Fractures and Lower Extremity Edema After Definitive Chemoradiation for Squamous Cell Carcinoma of the Anal Canal
13. Mixed Methods Evaluation of a Targeted One-Week Virtual Radiation Oncology Intensive Shadowing Experience for Medical Students Underrepresented in Medicine: Mentor's Perspective
14. Prediction of Outcomes after Radiotherapy for Hepatocellular Carcinoma Independently Validated Using Multi-Institutional Data
15. Phase Ib Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
16. Total Neoadjuvant Therapy versus Neoadjuvant Chemoradiotherapy in the Management of Gastric Cancer
17. Multi-institutional Retrospective Study Evaluating Ablative Radiotherapy of Liver Metastases from Pancreatic Cancer
18. Dose Escalation Radiation with IORT for Unresectable Pancreatic Cancer in the Era of FOLFIRINOX
19. Long Term Follow-up of a Phase II Study of Autophagy Inhibition with Hydroxychloroquine (HCQ) and Preoperative (Preop) Short Course Chemoradiation (SCRT) Followed by Early Surgery for Resectable Ductal Adenocarcinoma of the Head of Pancreas (PDAC)
20. Neoadjuvant versus Postoperative Chemoradiotherapy in Gastric Cancer
21. Lymph Node Retrieval Following Neoadjuvant Therapy in Patients with Rectal Cancer: Does It Affect The Predictability of Neoadjuvant Rectal Cancer (NAR) Score?
22. Gender Disparities in Philanthropic Fundraising by Academic Oncologists
23. Effect of Mismatch Repair Status on Outcome of Early Stage Grade 1-2 Endometrial Cancer Treated With Vaginal Brachytherapy
24. Patterns of Care for Older versus Younger Patients with Pancreatic Cancer
25. Evolutionary Analysis of Pre- and Post-treatment Molecular Diversity in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation (CRT) and a KRAS Mutation-targeted Radiosensitizer
26. Survival Benefit from Adjuvant Radiotherapy by Gastric Cancer Histologic Type: A National Cohort Study
27. Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-Adjusted Analysis
28. A Pilot Study of Neoadjuvant FOLFIRINOX followed by Chemoradiation for Gastric and Gastroesophageal Cancer: Preliminary Results and Prognostic Implications of ctDNA
29. Local Therapy for a Systemic Disease: Indications and Impact of Radiation Therapy to the Pancreatic Primary in Metastatic Pancreatic Cancer
30. Dosimetric Analysis and NTCP Model for Child-Pugh Score and ALBI Increase after Hepatic Irradiation
31. Longitudinal Follow-up of Women who received Pelvic Radiation for Lower GI or Gynecologic Cancers
32. Evaluating the Impact of Combination of Nivolumab and Ipilimumab to Liver/Lung SBRT on Local Control for Colorectal and Pancreatic Cancer: A Pooled Analysis of Two Prospective Trials
33. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma
34. Intraoperative radiation therapy (IORT) for borderline resectable and locally advance pancreatic cancer (BR/LA PDAC) in the era of modern neoadjuvant treatment: short- and long-term outcomes
35. Hospital readmissions following percutaneous liver tumor ablation using the nationwide readmissions database
36. Neoadjuvant therapy does not alter pattern of progression in pancreatic adenocarcinoma
37. Association of Dosimetric and Treatment Related Factors with Radiation Induced Lymphopenia and Overall Survival among Patients Treated in the FOLFIRINOX Era
38. Proton Therapy and the Role of Dosimetric Parameters as Predictors for Normal Tissue Complications after Liver-Directed Stereotactic Body Radiation Therapy
39. Cost-Effectiveness of Short Course Radiation Therapy Versus Long-Course Chemoradiation for Locally Advanced Rectal Adenocarcinoma
40. Patterns of Failure and Need for Biliary Intervention among Patients with Biliary Tract Cancers Treated with Definitive Surgery and Adjuvant Chemoradiation
41. Circulating Tumor DNA to Predict Surgical Outcome after Neoadjuvant Chemoradiation for Borderline Resectable/Locally Advanced Pancreatic Cancer
42. A Pilot Feasibility Study of Definitive Concurrent Chemoradiation with Pencil Beam Scanning Proton Beam in Combination with 5-fluorouracil and Mitomycin-c for Carcinoma of the Anal Canal
43. The Immune Milieu of Anal Squamous Cell Carcinoma: IDO Expression is Correlated with Poor Outcome
44. Enhancement of anti-tumor immunity and survival prolongation by neoadjuvant 5-FU, oxaliplatin and irinotecan (folfirinox) in pancreatic ductal adenocarcinoma patients
45. Genomic Evolution and Acquired Resistance to Pre-Operative Chemoradiation Therapy in Locally Advanced Rectal Cancer
46. End-of-Life Care for Patients with Potentially Resectable Pancreatic Cancer Who Received Radiation Therapy
47. Hepatocyte Growth Factor is Associated With Liver Dysfunction and Survival: Biomarker Results of a Phase 2 Study of Proton Beam Therapy in Patients with Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
48. Safety and Tolerability of Liver Re-Irradiation
49. Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer
50. Change in Platelet Count and Normal Liver Dosimetry in Patients Receiving Proton Radiation Therapy for Unresectable Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.